Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Quantum Mitohormesis (QMT) (M2101)

K-Number: K240348 · 2024-12-19

ApplicantQuantumtx Pte. , Ltd.
Decision Date2024-12-19
Product CodeIPF
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

Quantum Mitohormesis (QMT) (M2101) is a medical device manufactured by Quantumtx Pte. , Ltd.. It received FDA 510(k) clearance on 2024-12-19 under approval number K240348. The device is classified under product code IPF. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Quantum Mitohormesis (QMT) (M2101)?

Quantum Mitohormesis (QMT) (M2101) is a medical device that received FDA 510(k) clearance on 2024-12-19. It is manufactured by Quantumtx Pte. , Ltd.. The 510(k) number is K240348.

When was Quantum Mitohormesis (QMT) (M2101) approved by the FDA?

Quantum Mitohormesis (QMT) (M2101) received FDA 510(k) clearance on 2024-12-19, under approval number K240348.

What company makes Quantum Mitohormesis (QMT) (M2101)?

Quantum Mitohormesis (QMT) (M2101) is manufactured by Quantumtx Pte. , Ltd..

What is the FDA product code for Quantum Mitohormesis (QMT) (M2101)?

The FDA product code for Quantum Mitohormesis (QMT) (M2101) is IPF.

Related Devices (Code: IPF)

K160614Xcite Clinical StationRestorative Therapies, Inc. K163067CyMedica e-vive™ System; CY-1000Cymedica Orthopedics, Inc. K160992HPM-6000BTL Industries, Inc. K151922StimSox(TM) SystemStimmed, LLC K153696Chattanooga Revolution WirelessDjo, LLC K160299geko(TM) Plus R-2 Neuromuscular StimulatorFirstkind Limited

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑